MedPath

Fentanyl

Generic Name
Fentanyl
Brand Names
Abstral, Actiq, Duragesic, Effentora, Fentora, Instanyl, Lazanda, Sublimaze, Subsys, PecFent
Drug Type
Small Molecule
Chemical Formula
C22H28N2O
CAS Number
437-38-7
Unique Ingredient Identifier
UF599785JZ
Background

Fentanyl, a potent opioid agonist, was developed in the 1950s to fill a need for strong and rapid analgesia. Because of these characteristics, fentanyl is commonly used to treat chronic cancer pain or in anesthesia. Fentanyl is related to other opioids like morphine and oxycodone.

Fentanyl's high potency has also made it a common adulterant in illicit drugs, especially heroin. In 2017, 47600 overdose deaths in the United States involved some opioid (over 2/3 of all overdose deaths). Opioid overdoses kill an average of 11 Canadians daily.

Fentanyl was FDA approved in 1968.

Indication

Fentanyl intravenous or intramuscular injections are indicated for short term analgesia during induction, maintenance, and recovery from general or regional anesthesia. These injections are also used with a neuroleptic for premedication, induction, and as an adjunct to maintenance of anesthesia. Finally, fentanyl intravenous or intramuscular injections are used with oxygen for anesthesia in high risk patients.

Fentanyl sublingual tablets, transmucosal lozenges, buccal tablets, sublingual sprays, transdermal systems, and nasal sprays are indicated for the management of breakthrough pain in opioid tolerant cancer patients who require around the clock pain management.

Associated Conditions
Cancer Related Pain (Breakthrough Pain), Severe, Chronic Pain
Associated Therapies
Anesthetic premedication therapy, Anesthetics Agent, General Anesthesia, Induction of anesthesia therapy, Maintenance of anesthesia therapy, Regional Anesthesia therapy

Single Shot Intrathecal Analgesia in Vaginal Delivery

Not Applicable
Recruiting
Conditions
Effectiveness of Single Shot Intra-thecal Analgesia in Multiparous Women Scheduled for Normal Vaginal Delivery
Interventions
First Posted Date
2023-08-21
Last Posted Date
2023-08-21
Lead Sponsor
Ain Shams University
Target Recruit Count
75
Registration Number
NCT05998551
Locations
🇪🇬

Ainshams University, Cairo, Egypt

Evaluation of the Postoperative Agitation Prevention and Analgesic Efficacy of Perioperative Dexmedetomidine Infusion in a Pediatric Patient Group to Undergo Tonsillectomy and Adenoidectomy

Completed
Conditions
Anxiety
Postoperative Pain
Bleeding
Interventions
First Posted Date
2023-08-14
Last Posted Date
2023-11-08
Lead Sponsor
Burak Omur
Target Recruit Count
80
Registration Number
NCT05986942
Locations
🇹🇷

Istanbul Medipol University, Istanbul, Turkey

Paracetamol Plus Tramadol Versus Fentanyl in Day Case Surgeries

Recruiting
Conditions
Post Operative Pain
Interventions
First Posted Date
2023-08-14
Last Posted Date
2024-02-28
Lead Sponsor
Zagazig University
Target Recruit Count
132
Registration Number
NCT05990686
Locations
🇪🇬

Zagazig University , Fuculty of Medicine, Zagazig, Sharquia, Egypt

Genicular and Anterior Femoral Cutaneous Nerve Blocks for Total Knee Arthroplasty

Phase 4
Recruiting
Conditions
Genicular Nerve Block
Opioid Use
Total Knee Replacement
Interventions
First Posted Date
2023-08-08
Last Posted Date
2024-12-27
Lead Sponsor
Hospital for Special Surgery, New York
Target Recruit Count
244
Registration Number
NCT05980546
Locations
🇺🇸

Hospital for Special Surgery, New York, New York, United States

Hemodynamic Effects of Bolus of Ketamine Versus Fentanyl in Patients With Septic Shock

Not Applicable
Completed
Conditions
Fentanyl
Septic Shock
Ketamine
Interventions
First Posted Date
2023-07-24
Last Posted Date
2023-12-22
Lead Sponsor
Cairo University
Target Recruit Count
86
Registration Number
NCT05957302
Locations
🇪🇬

Ahmed Mohamed Hasanin, Cairo, Egypt

Symptom-inhibited Fentanyl Induction

Phase 4
Recruiting
Conditions
Opioid Use Disorder
Interventions
First Posted Date
2023-06-15
Last Posted Date
2024-07-18
Lead Sponsor
Pouya Azar
Target Recruit Count
50
Registration Number
NCT05905367
Locations
🇨🇦

Hope to Health Research & Innovation Centre, Vancouver, British Columbia, Canada

Comparison of Patient-controlled Analgesia Regimenfor Postoperative Pain in Patients Undergoing Total Knee Arthroplasty

Not Applicable
Completed
Conditions
Postoperative Pain, Acute
Interventions
First Posted Date
2023-05-17
Last Posted Date
2024-07-15
Lead Sponsor
Chung-Ang University Gwangmyeong Hospital
Target Recruit Count
98
Registration Number
NCT05861791
Locations
🇰🇷

ChungAng University Gwangmyeong Hospital, Gyeonggi-do, Gwangmyeon-si, Korea, Republic of

A Study to Investigate of the Effects of Opioid Exposure on the Ability of the Diaphragm Muscle

Phase 4
Recruiting
Conditions
Respiratory Function Loss
Respiratory Complication
Interventions
First Posted Date
2023-05-12
Last Posted Date
2024-07-12
Lead Sponsor
Mayo Clinic
Target Recruit Count
200
Registration Number
NCT05856136
Locations
🇺🇸

Mayo Clinic Minnesota, Rochester, Minnesota, United States

Effectiveness of Combining Erector Spinea Block With Non Opioid Infusions as Opioid Free Anesthesia in Spine Surgeries.

First Posted Date
2023-05-09
Last Posted Date
2023-05-09
Lead Sponsor
Ain Shams University
Target Recruit Count
140
Registration Number
NCT05850468
Locations
🇪🇬

Ainshams hospitals, Cairo, Egypt

Efficacy of Erector Spinae Plane Block Analgesia After Off Pump Cardiac Surgery

Not Applicable
Completed
Conditions
Postoperative Pain
Interventions
Procedure: Erector spinae block
First Posted Date
2023-03-15
Last Posted Date
2024-03-19
Lead Sponsor
Menoufia University
Target Recruit Count
50
Registration Number
NCT05769309
Locations
🇪🇬

Menoufia university, Cairo, Shibin Elkom, Egypt

© Copyright 2025. All Rights Reserved by MedPath